Despite impressive strides, multidetector CT scanner technology could still use some tweaking to maximize its utility, according to a speaker at the seventh annual Symposium on Multidetector-Row CT in San Francisco.
Despite impressive strides, multidetector CT scanner technology could still use some tweaking to maximize its utility, according to a speaker at the seventh annual Symposium on Multidetector-Row CT in San Francisco.
"We need more flexibility in handling the imaging data," said Dr. Willi Kalender, a radiology researcher at the University of Erlangen in Germany. "These are not necessarily features that are technology-driven. We have to ask ourselves what is needed clinically."
Tasked to come up with five features still needed to optimize multislice CT, Kalendar first outlined general goals for CT systems: shorter scan times for reliable cardiac imaging and larger z-axis coverage for perfusion measurements in the brain, heart, and lungs.
Achieving those goals means developing a system with multiple sources and detectors, for higher peak x-ray power and shorter scan times, he said. Such a CT system, whether using multiple or segmented detectors, would also be capable of higher spatial resolution for fluoroscopy and radiography.
A third item on the top five wish list would be a system with more tissue parameters to allow radiologists to escape the Hounsfield unit "cage," Kalendar said. His fourth desirable feature was interactively variable isotropic spatial resolution, which would be particularly useful in cardiac imaging.
Last but not least, Kalender would like to see CT established as a low-dose modality.
"With the advent of automatic exposure control, CT already is a low-dose modality, but that is not the widely held perception," he said. "We need to change that."
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.